Biofortuna to Use TriLink dNTPs in Diagnostic PCR Kits
September 16, 2010
Biofortuna to Use TriLink dNTPs in Diagnostic PCR Kits
Biofortuna will use the dNTPs for a line of human leukocyte antigen diagnostic kits it is developing for the transplantation, blood grouping, disease identification, and pharmacogenetic markets.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.